News archive for August 2005
Showing page 1 of 1
2005-08-01 07:00:00
... sociated with 120 fatal reports, the FDA issues a health advisory and the drug company revises the drug's warning label. Duragesic (fentanyl transdermal system CII) is an adhesive "pain patch" that is prescribed to persons suffering from chronic and/or debilitating pain such as arthritis. This pain medication or analgesic delivers a steady dose of fentanyl, a powerful opiate, to alleviate pain over an extended period of time (24-72 hours). The drug's new "black box" warning label states, "Since the peak fentanyl levels occur between 24 and 72 h ...
2005-08-29 07:00:00
... ked PPH with the use of appetite suppressants and weight loss drugs. Specifically, a study published in the New England Journal of Medicine (1996) found that the use of Fen Phen for three months or longer increased the risk of developing PPH by 23%. Responding to reports of heart disease linked to Fen-Phen and other weight loss prescription drugs, the FDA recalled the popular diet drugs Redux (dexfenfluramine), Pondimin (fenfluramine) and Fen-Phen (fenfluramine and phentermine) in 1997. Before they were recalled, these appetite suppressants wer ...
You can suggest a news source.